260 related articles for article (PubMed ID: 17079945)
1. The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Kanno A; Satoh K; Kimura K; Hirota M; Umino J; Masamune A; Satoh A; Asakura T; Egawa S; Sunamura M; Endoh M; Shimosegawa T
Pancreas; 2006 Nov; 33(4):391-6. PubMed ID: 17079945
[TBL] [Abstract][Full Text] [Related]
2. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
3. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
4. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
[TBL] [Abstract][Full Text] [Related]
5. Mucin expression profile in pancreatic cancer and the precursor lesions.
Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S
J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199
[TBL] [Abstract][Full Text] [Related]
6. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
[TBL] [Abstract][Full Text] [Related]
7. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
8. MUC1 and HER2 might be associated with invasive phenotype of intraductal papillary mucinous neoplasm.
Ohira G; Kimura K; Yamada N; Amano R; Nakata B; Doi Y; Murata A; Yashiro M; Tanaka S; Ohsawa M; Wakasa K; Hirakawa K
Hepatogastroenterology; 2013; 60(125):1067-72. PubMed ID: 23635475
[TBL] [Abstract][Full Text] [Related]
9. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
10. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and morphological characteristics of intraductal papillary mucinous tumors of the pancreas].
Dubova EA; Shchegolev AI
Arkh Patol; 2009; 71(2):9-12. PubMed ID: 19507570
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
[TBL] [Abstract][Full Text] [Related]
13. CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas.
Miyasaka Y; Nagai E; Ohuchida K; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
Pancreas; 2010 Jan; 39(1):31-5. PubMed ID: 19952968
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
Hibi Y; Fukushima N; Tsuchida A; Sofuni A; Itoi T; Moriyasu F; Mukai K; Aoki T
Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
[TBL] [Abstract][Full Text] [Related]
15. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
Hong SP; Lee EK; Park JY; Jeon TJ; Bang S; Park S; Chung JB; Lee WJ; Kim H; Song SY
Oncol Rep; 2009 Jan; 21(1):19-24. PubMed ID: 19082438
[TBL] [Abstract][Full Text] [Related]
16. Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenoma.
Handra-Luca A; Fléjou JF; Rufat P; Corcos O; Belghiti J; Ruszniewski P; Degott C; Bedossa P; Couvelard A
Histopathology; 2006 Jun; 48(7):813-21. PubMed ID: 16722930
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
Katabi N; Klimstra DS
J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
[TBL] [Abstract][Full Text] [Related]
18. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
Sanada Y; Kunita S; Yoshida K
Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
[TBL] [Abstract][Full Text] [Related]
19. Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases.
Rouzbahman M; Serra S; Adsay NV; Bejarano PA; Nakanuma Y; Chetty R
Pathology; 2007 Aug; 39(4):413-8. PubMed ID: 17676483
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
